The company in question is, Pfizer Inc. (NYSE:PFE) currently with a stock price of 32.5 (-0.49% today). The market cap for Pfizer Inc. is 197737.48, and is in the sector Healthcare, and Drug Manufacturers – Major industry. The target price for Pfizer Inc. is 39.4. Currently Pfizer Inc. is trading with a P/E of 28.84, and a forward P/E of 12.09. Average volume for Pfizer Inc. is 18715.44 and so far today it is 16888000.
Performance in the last year for Pfizer Inc. has been -2.16%. For EPS growth, Pfizer Inc. has seen a growth of -21.50%, and is looking to grow in the next year to 9.36%. More long term stats show that EPS growth has been 1.60% over the last five years and could be 6.05% for the next five years. Pfizer Inc. has seen sales growth quarter over quarter at -42.10%, with EPS growth quarter over quarter at -58.80%. The 20-day simple moving average is -5.31%, with the 200-day simple moving average coming to -0.61%.
Since the IPO date for Pfizer Inc. on the 6/1/1972, Pfizer Inc. has seen performance year to date to be 3.46%. With Pfizer Inc. trading at 32.5, the dividend yield is 3.69%, and the EPS is 1.13.
So could Pfizer Inc., be undervalued? Well as said before P/E is 28.84. The PEG is 4.77, P/S is 3.78 and the P/B is at 3.14. The P/cash is 9.44, with P/free cash flow at 32.69.
Pfizer Inc. ability to deal with debt shows that the current ratio is 1.4, and the quick ratio is 1.1. This is with long term debt/equity at 0.49, and total debt/equity at 0.7.
In terms of margins, Pfizer Inc. has a gross margin of 77.80%, an operating margin of 17.60% and a profit margin of 13.40%.Payout ratio for Pfizer Inc. is 101.70%. Return on assets come to 4.20% with return on investment coming to 7.30%.
Insider ownership for Pfizer Inc., is at 0.04% and institutional ownership comes to 71.70%. Outstanding shares are at 6084.23. While shares float is 6053.64. The float short is currently 0.72%, and short ratio is 2.33.